Eplerenone reduces arterial thrombosis in diabetic rats

New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats

(2014) Janusz Szemraj et al.   Pharmacological Reports

Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?

(2013) S. B. Bender et al.   DIABETES

Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity

(2013) Zhanyang Yu et al.   THROMBOSIS AND HAEMOSTASIS

Cardiovascular Risk Factors in a Patient with Diabetes Mellitus and Coronary Artery Disease: Therapeutic Approaches to Improve Outcomes: Perspectives of a Preventive Cardiologist

(2012) Michael H. Davidson   AMERICAN JOURNAL OF CARDIOLOGY

Antithrombotic Properties of Water-Soluble Carbon Monoxide-Releasing Molecules

(2012) Karol Kramkowski et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque

(2012) Omar de Rita et al.   CANADIAN JOURNAL OF CARDIOLOGY

Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis

(2012) Bartlomiej Kalaska et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Serotonin Potentiates High-Glucose^|^ndash;Induced Endothelial Injury: the Role of Serotonin and 5-HT2A Receptors in Promoting Thrombosis in Diabetes

(2012) Kumi Yamada et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

C0050 Eplerenone, a new selective mineralocorticoid receptor antagonist, inhibits platelet adhesion and attenuates endothelial damage in arterial thrombosis model in diabetic rats

(2012) Ewa Chabielska et al.   THROMBOSIS RESEARCH

Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats

(2012) Jae Hee Ahn et al.   Diabetes & Metabolism Journal

Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure

(2011) Fabrice Ivanes et al.   EUROPEAN HEART JOURNAL

Study of the mechanisms of aldosterone prothrombotic effect in rats

(2011) Anna Gromotowicz et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies

(2010) C. Longstaff et al.   BLOOD

Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2

(2009) Thomas W Jax et al.   Cardiovascular Diabetology

Tissue Factor and Cardiovascular Disease:

(2009) Alexander Breitenstein et al.   CIRCULATION JOURNAL

Role of Mineralocorticoid Receptor on Experimental Cerebral Aneurysms in Rats

(2009) Yoshiteru Tada et al.   HYPERTENSION

Eplerenone does not attenuate diabetes-associated atherosclerosis

(2009) Philip JW Koh et al.   JOURNAL OF HYPERTENSION

Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium

(2008) Elodie Ducros et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Aldosterone and Vascular Inflammation

(2008) Nancy J. Brown   HYPERTENSION

Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS

(2007) J. H. O’Keefe et al.   DIABETES OBESITY & METABOLISM